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Nowadays, the modern biotechnology industry is an emerging strategic industry of the 21st
century. In recent years, Singapore’s biomedical science(BMS) industry has developed rapidly and
become an important part of the global biomedical value chain. Since Singapore implemented The
Biomedical Science Initiative (BMS Initiative), biomedical science industry has entered a new phase
of development. Biomedical science industry is gradually becoming an emerging economic pillar. In
the international arena, the competitiveness of Singapore’s biomedical manufacturing has a great
improvement when compared with China, Japan and India, which are the major competitors to
Singapore in Asia. While its international competitiveness in pharmaceuticals follows close behind
India which has the greatest competitive advantage, Singapore is the strongest competitor out of
these four countries in medical technology product manufacturing.
This paper applies theories on global value chain and industry international competitiveness,
elaborates the development of biomedical science industry in Singapore, and analyzes its
international competitiveness. Government and MNCs are regarded as the facilitators for Singapore’s
BMS industry’s development. With the argument of these two main factors of the influence, it
attempts to summarize experiences from Singapore’s BMS industry development.
The paper consists of following six chapters. Chapter One is the introduction. It contains the
significance of the selected topic, the literature review and the research methods and framework.
Chapter Two describes theories on policy framework of global value chain and the relationship
between government’s behavior and industry international competitiveness, and illustrates the
appraisal system of international competitiveness based on import & export data. Chapter Three
states the development of biomedical science industry in Singapore, indicating its influence on
domestic economic development and exploring biomedical manufacturing’s international
competitiveness with the comparisons among China, Japan and India. On the basis of sorting out the
industrial policies, Chapter Four demonstrates the relationship between the government actions and
BMS industry development. Chapter Five discusses MNCs’ influences on BMS industry with a case















experiences of Singapore biomedical science industry, and puts forward its significance to China.
Singapore’s experience suggests that the development of an emerging industry requires the
support of government industrial policies to create the best investment and operating environment for
the industry. At the same time, an economy should make full use of and participate in the global
value chain dominated by MNCs, which could leads itself to a good position in the fierce
international competition relying on its own comparative advantages.
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向具区域特色的产业发展。③ 根据经济学人智库（Economist Intelligence Unit）2012年的报告，
随着地区经济高速增长和人口结构快速转变，亚洲制药部门正在迅速发展，其主要表现有：首
先，亚洲地区医药销售额的迅速增加。2001年亚洲地区医药销售额为 970亿美元，至 2010 年
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态系统模型（the high-skill ecosystems model, HSE model），检验新加坡生物技术产业集群发展
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